Snapshot · UnitedHealth Group Incorporated (UNH)

Data as of 2026-10-18T09:39:21.513Z

Fundamentals check

Market cap

$360.3B

P/E (TTM)

22.9

Gross margin

22.8%

Net margin

3.5%

ROE

16.1%

R&D / revenue

0.0%

Dividend yield

2.3%

FCF yield

6.3%

Latest dividend: $2.32/share (ex-date 2026-09-14, quarterly)

Summary

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.

How it makes money

Revenue mix, latest fiscal year

• Premiums78.7%
• Products11.9%
• Services8.5%
• Investment and other income0.9%

Recent Events

• 2026-10-17T14:47:01.000Zneutral

  UnitedHealth: 3 Key Takeaways for Long-Term Investors

  可能与长期投资者关注的盈利驱动相关，但无法确认直接因果。

  Source: fool.com

• 2026-10-17T03:47:24.000Znegative

  UnitedHealth Group Incorporated $UNH Holdings Boosted by Annex Advisory Services LLC

  恰逢机构持仓变动报道，或有助于理解持仓压力，但不直接指示价格走向。

  Source: defenseworld.net

• 2026-10-16T22:05:01.000Zpositive

  UnitedHealth: Q3 Confirms The Bull Case

  恰逢季度利好与利润率改善，可能与股价支撑相关，但仍需观察持续性。

  Source: seekingalpha.com

• 2026-10-16T14:18:00.000Zneutral

  From Verizon to UnitedHealth, Corporate America Is Balking at ‘Tokenized' Stocks

  市场结构话题与公司股票发行相关，但与UNH具体股价关系不强，属于边缘相关。

  Source: wsj.com

• 2026-10-16T14:06:01.000Zmixed

  UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy?

  利润率改善可能有助于股价，但成员下降带来不确定性，需综合判断。

  Source: zacks.com

• 2026-10-14T00:00:00.000Zpositive

  Price move: UNH rose 4.7%

  UNH 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-21T00:00:00.000Zpositive

  Price move: UNH rose 3.5%

  UNH 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $477.46 from 13 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-08-21SellConway Patrick Hugh(officer: Chief Executive Officer, Optum)1,169 shares
• 2026-08-05SellConway Patrick Hugh(officer: Chief Executive Officer, Optum)500 shares

US Congress trading disclosures

• 2026-06-04John Boozman (AR)Purchase$1,001 - $15,000

Earnings Calendar

2027-01-20

EPS estimate: 2.27

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。